NCT07079189Recruiting
Effect of the Digital Livsstilsverktyget in Conjunction With a Large Language Model on Glycemic Control in Patients With Type 2 Diabetes.
Personalized Study of Type 2 Diabetes With the Lifestyle Tool
Source: ClinicalTrials.gov · Last updated 14 Aug 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The overall aim of the study is to observe the change of long-term metabolic control in patients with type 2 diabetes who have access to a digital intervention tool as compared with randomized controls during one year. The tool is based on self-affirmation theory and has large emphasis on self-reflection to enable sustainable lifestyle changes. Users get access to expert-written information about relevant health topics and interact with an LLM to promote reflection on the information.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 300 (estimated)
- First submitted
- 13 Jul 2025
- Start date
- 11 Aug 2025
- Primary completion date
- 31 May 2027
- Lead sponsor
- Region Skane
- Diseases
- Type 2 diabetes
- NCT number
- NCT07079189
What you commit to
- Study type: Interventional
- Planned participants: 300
- From 11 Aug 2025 to the primary completion date, 31 May 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Treatment with insulin
- Change of anti-diabetic treatment with three months prior to inclusion
Other illness
- Condition or treatment that in the judgement of the Investigator precludes participation
Other
- Participation in other study that may affect the outcomes
- Inability to read and write in Swedish
- Work in competing areas
Who the study is looking for
- Patients with type 2 diabetes
- Diagnosis of diabetes mellitus was based on prior documentation or treatment with anti-hyperglycemic medication
- age at or above 35 years
- access to Internet
- informed consent
Age in the registry: 35 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Clinical Research Center Coordinator of this site? Confirm its status | Malmö | Sweden | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.